丁俊晖今晚直播现场,巜性刑房3捆绑凌虐BD中文字幕电影,电锯人第一季在线观看完整版高清

cis-Diamminechlorocholylglycinateplatinum(II)

NMR下載 COA and HPLC MSDS下載
names：
cis-Diamminechlorocholylglycinateplatinum(II)
CAS號：
191595-91-2
MDL Number：
MF(分子式)： C26H48ClN3O6Pt MW(分子量)： 729.22
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

cis-Diamminechlorocholylglycinateplatinum(II)

貨品編碼	規格	純度	價格 (￥)	現價(￥)	特價(￥)	庫存描述	數量	總計 (￥)
DBK501845-500mg	500mg		￥ 0.00	￥ 0.00		Get quote	- +	￥ 0.00
DBK501845-100mg	100mg		￥ 0.00	￥ 0.00		Get quote	- +	￥ 0.00

大包裝詢價提供各種包裝，敬請垂詢
收藏商品商品點評加入購物車立即購買

快速詢價

收起

你想詢價的產品

*產品名稱：

CAS號：

產品編號：

需求描述：

請準確填寫您的聯系方式，以便為您提供最好的服務。

*公司名稱：

*電子郵箱：

聯系人：

*電話：

*驗證碼：

詢價

中文別名	順式二氨基氯膽酸甘氨酸鉑（II）
英文別名	cis-Diamminechlorocholylglycinateplatinum(II)
CAS號	191595-91-2
Inchi
InchiKey
分子式 Formula	C26H48ClN3O6Pt
分子量 Molecular Weight	729.22
溶解度Solubility
性狀	Solid
儲藏條件 Storage conditions

cis-Diamminechlorocholylglycinateplatinum(II)使用注意事項：
1.實驗前需戴好防護眼鏡，穿戴防護服和口罩，佩戴手套，避免與皮膚接觸。
2.實驗過程中如遇到有毒或者刺激性物質及有害物質產生，必要時實驗操作需要手套箱內完成以免對實驗人員造成傷害。
3.取樣品的移液槍頭需及時更換，必要時為避免交叉污染盡可能選擇濾芯吸頭。
4.稱量藥品時選用稱量紙，并無風處取藥和稱量以免揚撒，試劑的容器使用前務必確保干凈，并消毒。
5.取藥品時盡量采用多個藥勺分別使用，使用后清洗干凈。
6.實驗后產生的廢棄物需分類存儲，并交于專業生物廢氣物處理公司處理，以免造成環境污染。
大規格定制：定制產品請將信息發送至sales@bio-fount.com。
Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.

產品說明	Cholecystokinin (CCK) is a peptide hormone discovered in the small intestine. Together with secretin and gastrin, CCK constitutes the classical gut hormone triad. In addition to gallbladder contraction, CCK also regulates pancreatic enzyme secretion and growth, intestinal motility, satiety signaling and the inhibition of gastric acid secretion. CCK is, however, also a transmitter in central and intestinal neurons. Notably, CCK is the most ubiquitously found neuropeptide in the human brain. Owing to difficulties in developing accurate assays for the hormone, knowledge about CCK secretion in disease is limited. Available data indicate, however, that proCCK is expressed in certain malignant neuroendocrine tumors and sarcomas, whereas the secretion of CCK is affected in celiac disease and the eating disorder bulimia nervosa. Stimulation with exogenous CCK has proved this protein useful in diagnostic imaging of gallbladder and pancreatic diseases, as well as testing of medullary thyroid carcinomas2,6,18.Cholecystokinin, a natural polypeptide which is formed in the amine precursor uptake and decarboxylation (APUD) cells of the proximal mucosa of the small intestine, promotes contraction of the gallbladder muscle, resulting in the reduction of gallbladder size and the expression of bile9. Cholecystokinin stimulates secretion of pancreatic digestive enzymes and secretion from the glands of Brunner9.CCK is composed of a five amino acid sequence at the carboxyl terminus that is identical to that of gastrin. The carboxyl terminus confers the biologic activity of CCK; as a result, gastrin has CCK-mimicking activity and CCK has gastrin-mimicking activity. The amino acid sequence similarity has made the creation of assays for CCK cumbersome, due to the fact that antibodies specific for the biologically active portion the molecule often cross-react with gastrin. This hormone circulates in the blood at concentrations 10 to 100 times greater than that of CCK14.TargetActionsOrganismUCholecystokinin receptor type AagonistHumansURAF proto-oncogene serine/threonine-protein kinaseagonistHumansUMitogen-activated protein kinase 3Not AvailableHumansUPro-epidermal growth factorNot AvailableHumansUProtein kinase C beta typeagonistHumansUGastrin/cholecystokinin type B receptoragonistHumans
Introduction	Not Available
Application1
Application2	Agonist
Application3